Federation des caisses Desjardins du Quebec’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-700
Closed -$3.46K 3132
2026
Q1
$3.46K Buy
+700
New +$3.41K ﹤0.01% 2578

Other funds holding SOPH

Federation des caisses Desjardins du Quebec's SOPH Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec sold out of SOPHiA GENETICS (SOPH) in Q2 2026, closing a stake of 700 shares — an estimated $3.46K sold.

Federation des caisses Desjardins du Quebec first reported a position in SOPH in Q1 2026 and held it in 1 quarter. The position peaked at $3.46K in Q1 2026. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining SOPHiA GENETICS position as of Q2 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 700 SOPHiA GENETICS shares in Q2 2026, an estimated $3.46K.
  • Federation des caisses Desjardins du Quebec first reported a position in SOPHiA GENETICS in Q1 2026 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's SOPHiA GENETICS position peaked at $3.46K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.